Inclusive Capital Partners Amends Ingevity Stake Filing

Ticker: NGVT · Form: SC 13D/A · Filed: 2024-02-28T00:00:00.000Z

Sentiment: neutral

Topics: amendment, insider-ownership, institutional-filing

Related Tickers: INGR

TL;DR

**Inclusive Capital Partners just updated their Ingevity filing, signaling a change in their stake.**

AI Summary

Inclusive Capital Partners, L.P. filed an Amendment No. 3 to their Schedule 13D on February 26, 2024, regarding their ownership in Ingevity Corporation. The filing indicates a change in the information previously reported, specifically concerning the date of the event requiring the filing. The original filing was made under the Securities Exchange Act of 1934, with Ingevity Corporation's common stock having a CUSIP number of 45688C107.

Why It Matters

This amendment signals a change in the reporting entity's position or intent regarding Ingevity, which could influence investor perception and stock performance.

Risk Assessment

Risk Level: low — This is an amendment to a previous filing, indicating a change in reporting rather than a new, aggressive position.

Key Players & Entities

FAQ

What is the purpose of this SC 13D/A filing?

This SC 13D/A filing is Amendment No. 3 to a Schedule 13D, indicating a change in the information previously reported by Inclusive Capital Partners, L.P. regarding their ownership in Ingevity Corporation.

Who is the subject company of this filing?

The subject company of this filing is Ingevity Corporation, with a CUSIP number of 45688C107 for its Common Stock.

When was the event that required this amendment?

The date of the event which required this amendment was February 26, 2024.

Who is authorized to receive notices and communications for Inclusive Capital Partners, L.P.?

Philippe B. Pradel of Inclusive Capital Partners, L.P. is authorized to receive notices and communications, with legal counsel provided by Eleazer Klein, Esq. and Adriana Schwartz, Esq. of Schulte Roth & Zabel LLP.

What is the CUSIP number for Ingevity Corporation's securities?

The CUSIP number for Ingevity Corporation's Common Stock, par value $0.01 per share, is 45688C107.

Filing Stats: 1,034 words · 4 min read · ~3 pages · Grade level 9.6 · Accepted 2024-02-28 17:30:32

Key Financial Figures

Filing Documents

of the Schedule 13D is hereby amended and supplemented by the addition of the following

Item 6 of the Schedule 13D is hereby amended and supplemented by the addition of the following: Mr. Slocum holds a total of 5,034 vested and unvested deferred stock units (" DSU s") pursuant to his election to receive DSUs in lieu of the annual non-employee director restricted stock unit grant and quarterly director fees. These DSUs will settle into an equal number of the Issuer's Shares upon Mr. Slocum's termination of board service pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan and 2016 Omnibus Incentive Plan, as amended. Mr. Slocum is deemed to hold the Shares for the benefit of the In-Cap Funds and indirectly for the benefit of In-Cap, and may, after vesting, if applicable, transfer the Shares directly to the In-Cap Funds. CUSIP No. 45688C107 SCHEDULE 13D/A Page 5 of 5 Pages

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: February 28, 2024 Inclusive Capital Partners, L.P. By: /s/ Philippe B. Pradel Name: Philippe B. Pradel Title: Chief Compliance Officer /s/ Jeffrey W. Ubben JEFFREY W. UBBEN

View on Read The Filing